Organization
Institut de Cancérologie de Lorraine
2 clinical trials
5 abstracts
Abstract
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.Org: Medical Oncology Department, Rene Gauducheau Cancer Center, Institut De Cancerologie D'Ouest Centre Paul Papin, Hôpital Saint Grégoire, Faculté de Médecine Paris-Sud,
Abstract
Prognostic impact of PSA nadir (n) ≥0.1 ng/mL within 6 months (m) after completion of radiotherapy (RT) for localized prostate cancer (PCa): An individual patient-data (IPD) analysis of randomized trials from the ICECAP collaborative.Org: Dana-Farber Cancer Institute, St. Luke’s Hospital, Division of Urology, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Tor Vergata University of Rome,
Abstract
Clinical utility of ctDNA as a tool to detect triple-negative breast cancer relapses: The CUPCAKE trial.Org: Institut Curie, Saint Cloud, France, Institut Bergonie, Centre Jean Perrin, Centre Léon Bérard, Institut Paoli Calmettes,
Clinical trial
Evaluation of the Ability of PpIX Fluorescence to Mark High-grade Vulvar Intraepithelial Neoplasia Following the Methyl Aminolevulinate (Metvixia®) ApplicationStatus: Recruiting, Estimated PCD: 2024-12-17
Clinical trial
Two Arm, Prospective, Multicenter Randomized Phase II Trial of Neoadjuvant Modified Folfirinox Regimen, With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic CarcinomaStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Abstract
Impact of positive resection margins on recurrence and survival following resection and adjuvant chemotherapy in pancreatic cancer: Results of the PRODIGE 24-CCTG PA-6 trial.Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Lorraine Cancer Institute, Nancy N and J C Lewis Cancer and Research Pavilion, France, Institut de Cancérologie de Lorraine,
Abstract
Early palliative care for patients with metastatic upper gastrointestinal cancers: A survival analysis of the EPIC randomized trial.Org: Institut du Cancer de Montpellier, Centre Oscar Lambret, Institut de Cancérologie de l'Ouest, Angers, France, Digestive Oncology, Hopital Duchenne, Medical Oncology Department, Lille University Hospital, University of Lille, Lille, France,